Batash, R.; Asna, N.; Ali, S.H.; Charkovsky, T.; Asali, M.; Pelles, S.; Schaffer, M.
Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Oncologic Patients—A New Promise? Preliminary Results. Cancers 2025, 17, 3321.
https://doi.org/10.3390/cancers17203321
AMA Style
Batash R, Asna N, Ali SH, Charkovsky T, Asali M, Pelles S, Schaffer M.
Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Oncologic Patients—A New Promise? Preliminary Results. Cancers. 2025; 17(20):3321.
https://doi.org/10.3390/cancers17203321
Chicago/Turabian Style
Batash, Ron, Noam Asna, Sara HaJ Ali, Tatiana Charkovsky, Murad Asali, Sharon Pelles, and Moshe Schaffer.
2025. "Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Oncologic Patients—A New Promise? Preliminary Results" Cancers 17, no. 20: 3321.
https://doi.org/10.3390/cancers17203321
APA Style
Batash, R., Asna, N., Ali, S. H., Charkovsky, T., Asali, M., Pelles, S., & Schaffer, M.
(2025). Management of Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Oncologic Patients—A New Promise? Preliminary Results. Cancers, 17(20), 3321.
https://doi.org/10.3390/cancers17203321